Most Recent
Katy Perry back in court in trade mark fight with designer
A trade mark dispute between US singer Katy Perry and an Australian fashion designer is back in court for a fight on damages and injunctions, after the designer secured a win before the High Court in March.
Jones Day raids top firms for talent
Jones Day is making moves on its rivals, luring leading lawyers across disputes, real estate, energy, corporate and IP from a who's who of top firms.
Cement Australia fights amendments to Boral’s ‘green’ cement patent
Cement Australia has appealed a decision allowing Boral to amend its patent for a lower carbon cement, after losing its argument that the changes would broaden the scope of the patent.
AirTrunk obtains docs from rival Zerra in data centre fight
Data centre operator AirTrunk has secured access to documents from competitor Zerra DC -- including the complete set of design documents for a Victorian data centre -- as it weighs a potential intellectual property case.
AFL may be pulled into footy card misuse of market power case
The AFL might be dragged into a competition case by trading card company Select Cards accusing memorabilia maker SEP of misuse of market power, a court has heard.
Light & Wonder, Aristocrat back in the ring after $190M settlement
Game maker Light & Wonder is facing off again in court against rival Aristocrat, which it recently paid $190 million to for alleged trade secrets theft, seeking discovery to suss out whether it has a patent revocation case.
Bodum can’t dodge costs in failed cup design case, despite appeal
A judge has made orders for kitchenware company Bodum to pay rival Maxwell & Williams' costs in a design dispute over stylish coffee glasses, despite Bodum's impending appeal.
Adidas sues teen fave White Fox for trade mark infringement
Adidas has brought trade mark infringement proceedings against teen fashion brand White Fox.
OpenAI calls for ‘balanced’ approach to copyright
ChatGPT owner OpenAI has called on the Albanese government to adopt a "balanced" approach to copyright that would allow AI to learn from publicly available information and collaborate with copyright owners.
Pfizer loses patent case over Enbrel generic
Pfizer has lost a patent infringement lawsuit against Samsung Bioepis over the generic version of its blockbuster autoimmune drug Enbrel, with a judge finding all but one of the patent's claims is invalid.